Stock listing

4BB Stock Price, News, Filings & Events — 4basebio Plc

Selected listing: 4BB · LSE · GBX · GB

This page tracks 4basebio Plc's 4BB:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4BB:LSE. 4BB:LSE is the stock-level entry point for investors researching 4basebio Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. 4basebio Plc is a public company listed on the UK market under the ticker 4BB, with a market capitalization of approximately £109.53 million. The company focuses on advancing biotechnology solutions, particularly in the field of DNA-based products and services. 4basebio aims to leverage its expertise to drive innovation and growth in the biopharmaceutical sector.

4BB:LSEGBXGBUpdated August 21, 2026
4basebio Plc logo
Ticker
4BB:LSE
Asset type
Stock
Market cap
$98.1M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSE
Currency
GBX

4basebio Plc 4BB:LSE stock context

This page tracks 4basebio Plc's 4BB:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4BB:LSE. 4BB:LSE is the stock-level entry point for investors researching 4basebio Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. 4basebio Plc is a public company listed on the UK market under the ticker 4BB, with a market capitalization of approximately £109.53 million. The company focuses on advancing biotechnology solutions, particularly in the field of DNA-based products and services. 4basebio aims to leverage its expertise to drive innovation and growth in the biopharmaceutical sector.

Latest news from 4basebio Plc

All 4basebio Plc news →

4basebio Plc earnings calls

Research 4basebio Plc

Alternate listings